NO931209D0 - Anordning for tarnsdermal tilfoersel av kontraseptiver - Google Patents

Anordning for tarnsdermal tilfoersel av kontraseptiver

Info

Publication number
NO931209D0
NO931209D0 NO1993931209A NO931209A NO931209D0 NO 931209 D0 NO931209 D0 NO 931209D0 NO 1993931209 A NO1993931209 A NO 1993931209A NO 931209 A NO931209 A NO 931209A NO 931209 D0 NO931209 D0 NO 931209D0
Authority
NO
Norway
Prior art keywords
tarnsdermal
optives
contrase
supply
progesterone
Prior art date
Application number
NO1993931209A
Other languages
English (en)
Other versions
NO931209L (no
NO303527B1 (no
Inventor
Robert M Gale
Diane E Nedberge
Linda E Atkinson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO931209D0 publication Critical patent/NO931209D0/no
Publication of NO931209L publication Critical patent/NO931209L/no
Publication of NO303527B1 publication Critical patent/NO303527B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Semiconductor Lasers (AREA)
  • Vending Machines For Individual Products (AREA)
  • Steroid Compounds (AREA)
NO931209A 1990-10-29 1993-03-31 Ïstrogenholdig medikament og anordning for transdermal administrering derav NO303527B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/605,726 US5122382A (en) 1990-10-29 1990-10-29 Transdermal contraceptive formulations, methods and devices
PCT/US1991/007877 WO1992007589A1 (en) 1990-10-29 1991-10-25 Transdermal contraceptive formulations, methods and devices

Publications (3)

Publication Number Publication Date
NO931209D0 true NO931209D0 (no) 1993-03-31
NO931209L NO931209L (no) 1993-04-26
NO303527B1 NO303527B1 (no) 1998-07-27

Family

ID=24424948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931209A NO303527B1 (no) 1990-10-29 1993-03-31 Ïstrogenholdig medikament og anordning for transdermal administrering derav

Country Status (16)

Country Link
US (1) US5122382A (no)
EP (1) EP0577602B1 (no)
JP (1) JP2975684B2 (no)
AT (1) ATE171069T1 (no)
AU (1) AU9041991A (no)
CA (1) CA2088778C (no)
DE (1) DE69130232T2 (no)
DK (1) DK0577602T3 (no)
ES (1) ES2123547T3 (no)
IE (1) IE913741A1 (no)
MX (1) MX9101784A (no)
NO (1) NO303527B1 (no)
NZ (1) NZ240361A (no)
PT (1) PT99340B (no)
WO (1) WO1992007589A1 (no)
ZA (1) ZA918531B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
DE69125855T2 (de) * 1990-06-01 1997-07-31 The Population Council, New York, N.Y. Therapeutisch wirksame, örtliche anwendung von st1435
US5320850A (en) * 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
MX9303557A (es) * 1992-08-06 1994-03-31 Beta Pharm Co Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
AU726283B2 (en) * 1995-06-28 2000-11-02 Schering Aktiengesellschaft Pharmaceutical combined preparations, kit and method for hormonal contraception
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
FR2739032B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
WO1999032153A1 (en) * 1997-12-22 1999-07-01 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
US6699497B1 (en) * 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
PT1140039E (pt) 1998-12-18 2010-02-03 Alza Corp Dispositivos transparentes de administração transdérmica de nicotina
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US20080097149A1 (en) * 2002-12-30 2008-04-24 Sam Adler Method for in Vivo Sensing
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US8518926B2 (en) * 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
WO2007121188A2 (en) * 2006-04-10 2007-10-25 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
AU2007253899A1 (en) * 2006-05-16 2007-11-29 Knopp Neurosciences, Inc. Compositions of R(+) and S(-) pramipexole and methods of using the same
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
RU2454409C2 (ru) 2007-03-14 2012-06-27 Нопп Ньюросайенсиз, Инк. Синтез хирально очищенных замещенных бензотиазолдиаминов
JP5603235B2 (ja) * 2007-07-10 2014-10-08 アージャイル セラピューティクス， インコーポレイテッド イン・サイチュシールを有する経皮送達デバイス
US20100292660A1 (en) * 2007-07-10 2010-11-18 Agis Kydonieus Dermal delivery device with ultrasonic weld
CA2734491A1 (en) * 2008-08-19 2010-02-25 Knopp Neurosciences, Inc. Compositions and methods of using (r)-pramipexole
AU2010262970A1 (en) * 2009-06-19 2012-01-12 Knopp Neurosciences, Inc. Compositions and methods for treating amyotrophic lateral sclerosis
JP6082249B2 (ja) 2009-12-17 2017-02-15 ザ・ポピュレイション・カウンシル，インコーポレイテッド 経皮ゲル製剤
AU2012205791B2 (en) 2011-01-10 2016-11-03 Invion, Ltd. Use of beta-adrenergic inverse agonists for smoking cessation
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
WO2013177570A1 (en) 2012-05-25 2013-11-28 Terapio Corporation Methods of preventing or treating disease of the central nervous system using rlip76
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
CN105764507B (zh) 2013-07-12 2019-07-19 诺普生物科学有限责任公司 治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
AU2014306683B2 (en) 2013-08-13 2017-10-12 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
WO2015042163A1 (en) 2013-09-17 2015-03-26 Terapio Corporation Methods of preventing or treating mucositis using rlip76

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800038A (en) * 1972-04-21 1974-03-26 Biolog Concepts Inc Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
CH674618A5 (no) * 1987-04-02 1990-06-29 Ciba Geigy Ag

Also Published As

Publication number Publication date
CA2088778C (en) 2001-08-14
IE913741A1 (en) 1992-05-22
ES2123547T3 (es) 1999-01-16
JPH06502429A (ja) 1994-03-17
DK0577602T3 (da) 1999-06-14
WO1992007589A1 (en) 1992-05-14
EP0577602A1 (en) 1994-01-12
JP2975684B2 (ja) 1999-11-10
ATE171069T1 (de) 1998-10-15
EP0577602B1 (en) 1998-09-16
PT99340B (pt) 1999-02-26
CA2088778A1 (en) 1992-04-30
NO931209L (no) 1993-04-26
NO303527B1 (no) 1998-07-27
AU9041991A (en) 1992-05-26
NZ240361A (en) 1995-07-26
MX9101784A (es) 1992-06-05
DE69130232D1 (de) 1998-10-22
DE69130232T2 (de) 1999-04-08
ZA918531B (en) 1992-08-26
PT99340A (pt) 1992-09-30
US5122382A (en) 1992-06-16

Similar Documents

Publication Publication Date Title
NO931209L (no) Anordning for tarnsdermal tilfoersel av kontraseptiver
FI950774A0 (fi) Valmiste käytettäväksi 3-ketodesogestreeliä sisältävään transdermaaliseen applikaatioon
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
FI903213A0 (fi) Foer transdermal administration avsett gestoden innehaollande medel.
ATE29965T1 (de) Analgetische und entzuendungshemmende zusammensetzungen mit gehalt an kaffein.
DK0557385T3 (da) Topiske sammensætninger til transdermal afgivelse af prodrug-derivater af morfin
FI963515A (fi) Laastarin muodossa oleva transdermaalinen systeemi, joka sisältää tamoksifeenijohdosta
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
ES458559A1 (es) Procedimiento de preparacion de una nueva composicion cosme-tica para la piel.
FI912160A (fi) Komposition foer behandling av osteoporos och hormonell obalans.
FI923088A (fi) Oktadekyl-(2-(n-metylpiperidino)-etyl)-fosfat och foerfarande foer dess framstaellning
NO912681L (no) Anordning for sammenfoeyning av delkomponenter i moebler.
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
JPS5229038A (en) Urinal device for automobile
GB2243717B (en) Bipolar transistor device
IT1258803B (it) Composizioni farmaceutiche comprendenti melatonina o un suo derivato-agonista, atte al trattamento dei disordini cerebro-vascolari
JPS5219186A (en) Flocculating agent
GR1000065B (el) Κεφαλη παροχης στιγμιαιου καφε και λοιπων ζεστων ροφηματων.
DE69104612D1 (de) Verstellbare sicherheitgurt-verankerung.
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene
JPS51148026A (en) Deodorizers
GR1001395B (el) Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
NO913424D0 (no) Anordning for vakumtransport av naaletrestiklinger i planteautomat.
IT1234536B (it) Sistema correttivo nelle calzature

Legal Events

Date Code Title Description
MK1K Patent expired